AstraZeneca, Ranbaxy Ask 1st Circ. To Affirm Nexium Win
By John Kennedy ( April 18, 2016, 9:22 PM EDT) -- AstraZeneca PLC and Ranbaxy Inc. told the First Circuit on Friday that it should affirm a Massachusetts federal court's ruling that purchasers of AstraZeneca's blockbuster heartburn drug Nexium couldn't get a new trial after a jury sided with the drugmakers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.